Inventor · disambiguated record
Changqing Wei
Also filed as: WEI CHANGQING
12 granted patents·2 pending applications·27 citations·filing 2015–2022
83Inventor score
Files withMEDSHINE DISCOVERY INC3ZHUHAI UNITED LABORATORIES CO LTD3CSTONE PHARMACEUTICALS SUZHOU CO LTD2CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1CISEN PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
14 records- 0190US9938292B2Quinoline derivatives as SMO inhibitorsGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2015·Granted Apr 10, 2018·19 cites·20 claims
- 0288US10745389B2HDAC6 selective inhibitors, preparation method therefor, and application thereofCSTONE PHARMACEUTICALS (SUZHOU) CO LTD·Filed 2018·Granted Aug 18, 2020·6 cites·17 claims
- 0380US11919896B2[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2019·Granted Mar 5, 2024·2 cites·19 claims
- 0460US12486266B2Crystalline form of JAK inhibitor and application thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2021·Granted Dec 2, 2025·0 cites·13 claims
- 0559US2025011332A1Pyrazolo fused ring compound and use thereofSOTER BIOPHARMA PTE LTD·Filed 2022·Application pending·0 cites
- 0658US11345682B2Polymorph of HDAC6-selective inhibitor and application thereofCSTONE PHARMACEUTICALS SUZHOU CO LTD·Filed 2019·Granted May 31, 2022·0 cites·8 claims
- 0753US12428391B2Dimethylsulfoximine derivativeCISEN PHARMACEUTICAL CO LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 0852US12391653B2Salt form and crystal form of mutant IDH1 inhibitor and preparation method thereforKPC PHARMACEUTICALS INC·Filed 2020·Granted Aug 19, 2025·0 cites·20 claims
- 0952US11427581B2JAK inhibitor and use thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2019·Granted Aug 30, 2022·0 cites·12 claims
- 1052US2023017539A1Tri-heterocyclic compound as jak inhibitor, and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 1150US11634424B2Diazaindole derivative and use thereof as CHK1 inhibitorMEDSHINE DISCOVERY INC·Filed 2020·Granted Apr 25, 2023·0 cites·13 claims
- 1249US12351590B2Pyrrolopyrimidine compound and use thereofGUANGZHOU JOYO PHARMATECH CO LTD·Filed 2020·Granted Jul 8, 2025·0 cites·17 claims
- 1348US11230544B1Substituted 1,3,4-thiadiazoles as GLS1 inhibitorsMEDSHINE DISCOVERY INC·Filed 2019·Granted Jan 25, 2022·0 cites·21 claims
- 1443US11254666B2Compound as GLS1 inhibitorMEDSHINE DISCOVERY INC·Filed 2018·Granted Feb 22, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Changqing Wei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →